Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Analysis of Liquidity Ratios

Microsoft Excel

Liquidity Ratios (Summary)

Moderna Inc., liquidity ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Current ratio 2.73 1.76 1.43 7.89 7.02
Quick ratio 2.29 1.52 1.37 7.74 6.89
Cash ratio 2.01 1.18 1.05 7.71 6.83

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Moderna Inc. current ratio improved from 2020 to 2021 and from 2021 to 2022.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Moderna Inc. quick ratio improved from 2020 to 2021 and from 2021 to 2022.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Moderna Inc. cash ratio improved from 2020 to 2021 and from 2021 to 2022.

Current Ratio

Moderna Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Current assets 13,431 16,071 6,298 1,129 1,563
Current liabilities 4,923 9,128 4,389 143 223
Liquidity Ratio
Current ratio1 2.73 1.76 1.43 7.89 7.02
Benchmarks
Current Ratio, Competitors2
AbbVie Inc. 0.96 0.79 0.84 3.18
Amgen Inc. 1.41 1.59 1.81 1.44
Bristol-Myers Squibb Co. 1.25 1.52 1.58 1.60
Eli Lilly & Co. 1.05 1.23 1.40 1.16
Gilead Sciences Inc. 1.29 1.27 1.40 3.10
Johnson & Johnson 0.99 1.35 1.21 1.26
Merck & Co. Inc. 1.47 1.27 1.02 1.24
Pfizer Inc. 1.22 1.40 1.35 0.88
Regeneron Pharmaceuticals Inc. 5.06 3.56 3.63 3.67
Thermo Fisher Scientific Inc. 1.48 1.50 2.13 1.92
Vertex Pharmaceuticals Inc. 4.83 4.46 4.33 3.61
Current Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 1.28 1.36 1.36 1.56
Current Ratio, Industry
Health Care 1.17 1.22 1.22 1.34

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 13,431 ÷ 4,923 = 2.73

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Moderna Inc. current ratio improved from 2020 to 2021 and from 2021 to 2022.

Quick Ratio

Moderna Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Cash and cash equivalents 3,205 6,848 2,624 236 658
Investments 6,697 3,879 1,984 867 863
Accounts receivable 1,385 3,175 1,391 5 13
Total quick assets 11,287 13,902 5,998 1,108 1,534
 
Current liabilities 4,923 9,128 4,389 143 223
Liquidity Ratio
Quick ratio1 2.29 1.52 1.37 7.74 6.89
Benchmarks
Quick Ratio, Competitors2
AbbVie Inc. 0.69 0.56 0.60 2.91
Amgen Inc. 0.95 1.06 1.30 1.01
Bristol-Myers Squibb Co. 0.87 1.20 1.28 1.26
Eli Lilly & Co. 0.63 0.80 0.85 0.68
Gilead Sciences Inc. 0.99 0.95 1.08 2.86
Johnson & Johnson 0.71 1.04 0.91 0.94
Merck & Co. Inc. 0.93 0.73 0.58 0.78
Pfizer Inc. 0.80 1.00 0.78 0.50
Regeneron Pharmaceuticals Inc. 4.16 2.98 2.86 2.81
Thermo Fisher Scientific Inc. 1.06 1.00 1.63 1.19
Vertex Pharmaceuticals Inc. 4.46 4.04 4.02 3.33
Quick Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.90 0.98 0.96 1.18
Quick Ratio, Industry
Health Care 0.87 0.90 0.91 1.01

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 11,287 ÷ 4,923 = 2.29

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Moderna Inc. quick ratio improved from 2020 to 2021 and from 2021 to 2022.

Cash Ratio

Moderna Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in millions)
Cash and cash equivalents 3,205 6,848 2,624 236 658
Investments 6,697 3,879 1,984 867 863
Total cash assets 9,902 10,727 4,608 1,103 1,521
 
Current liabilities 4,923 9,128 4,389 143 223
Liquidity Ratio
Cash ratio1 2.01 1.18 1.05 7.71 6.83
Benchmarks
Cash Ratio, Competitors2
AbbVie Inc. 0.31 0.28 0.30 2.56
Amgen Inc. 0.59 0.66 0.91 0.69
Bristol-Myers Squibb Co. 0.42 0.78 0.83 0.84
Eli Lilly & Co. 0.13 0.26 0.29 0.21
Gilead Sciences Inc. 0.57 0.56 0.65 2.50
Johnson & Johnson 0.42 0.70 0.59 0.54
Merck & Co. Inc. 0.54 0.34 0.30 0.47
Pfizer Inc. 0.54 0.73 0.47 0.26
Regeneron Pharmaceuticals Inc. 2.46 1.45 1.33 1.53
Thermo Fisher Scientific Inc. 0.50 0.33 1.00 0.39
Vertex Pharmaceuticals Inc. 3.93 3.51 3.55 2.85
Cash Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.51 0.59 0.58 0.81
Cash Ratio, Industry
Health Care 0.49 0.52 0.54 0.64

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 9,902 ÷ 4,923 = 2.01

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Moderna Inc. cash ratio improved from 2020 to 2021 and from 2021 to 2022.